Quasiparticles

SOLITON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Soliton, Inc. - SOLY

Retrieved on: 
Wednesday, May 12, 2021
Legal, Professional services, Calculus, Differential equations, Multivariable calculus, Foti, Fluid dynamics, Solitons, Quasiparticles, Nonlinear optics, AbbVie, KSF

b'Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

Key Points: 
  • b'Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
  • and the law firm of Kahn Swick & Foti, LLC (\xe2\x80\x9cKSF\xe2\x80\x9d) are investigating the proposed sale of Soliton, Inc. (NasdaqGS: SOLY) to AbbVie, Inc. (NYSE: ABBV).
  • Under the terms of the proposed transaction, shareholders of Soliton will receive only $22.60 in cash for each share of Soliton that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.\nIf you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( [email protected] ) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-soly/ to learn more.\nTo learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210512006041/en/\n'

Soliton Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cellulite

Retrieved on: 
Monday, February 1, 2021
Calculus, Differential equations, Multivariable calculus, Quasiparticles, Solitons

"We're thrilled to receive this latest clearance for our RAP technology," said Brad Hauser, President & CEO of Soliton.

Key Points: 
  • "We're thrilled to receive this latest clearance for our RAP technology," said Brad Hauser, President & CEO of Soliton.
  • Soliton RAP technology also received 510(k) clearance from the FDA for the removal of tattoos in mid 2019.
  • The Company is based in Houston, Texas, and is actively engaged in bringing the Rapid Acoustic Pulse ("RAP") device to the market.
  • The Company also believes the technology will provide the first non-invasive acoustic technology to be able to target the underlying cause of dimples and ridges in cellulite.

Phononic and Fabrinet Partner to Scale Global Production of High-Performance Thermoelectrics

Retrieved on: 
Monday, December 7, 2020
Consumer electronics, Automotive, Technology, Manufacturing, Semiconductor, Other Energy, Other Automotive, Telecommunications, Other Manufacturing, Energy, Mobile, Wireless, Bosons, Phonon, Quasiparticles, Competence, Optoelectronics, Fabrinet, Phononic

With 12 straight quarters of growth, Phononic forecasts to increase revenue in 2020 from their optoelectronics business unit by over 150% compared to 2019.

Key Points: 
  • With 12 straight quarters of growth, Phononic forecasts to increase revenue in 2020 from their optoelectronics business unit by over 150% compared to 2019.
  • We are very pleased to partner with Phononic to leverage our core technical competency while expanding our coverage of the optical component value chain, said Dr. Harpal Gill, President & COO of Fabrinet.
  • Phononic recognizes the global brand recognition from Fabrinets extensive experience in optical communications and believe Fabrinet is uniquely qualified to enable Phononic to meet its rapidly growing market demand.
  • In my 20 years in this industry, I have always seen Fabrinet as a critical go-to expansion partner, said Kevin Granucci, Vice President and GM of Phononic.

Soliton Appoints Niquette Hunt to Board of Directors

Retrieved on: 
Thursday, October 22, 2020
Calculus, Differential equations, Multivariable calculus, Quasiparticles, Solitons, Hyperhidrosis

HOUSTON, Oct. 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Niquette Hunt to its Board of Directors.Ms.

Key Points: 
  • HOUSTON, Oct. 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Niquette Hunt to its Board of Directors.Ms.
  • "We are thrilled to add Ms. Hunt to our Board of Directors," commented Dr. Christopher Capelli, Soliton Co-Founder and CEO.
  • Ms. Hunt brings more than 25 years of general management and commercialization experience leading consumer product and biotechnology companies.
  • Ms. Hunt founded Candesant Biomedical in 2016 to develop a novel, non-invasive treatment for those who suffer from excessive sweating.

Soliton Selects Lippe Taylor Group as its Public Relations and Customer Engagement Agency

Retrieved on: 
Tuesday, September 29, 2020
Calculus, Differential equations, Multivariable calculus, Nonlinear optics, Quasiparticles, Solitons

HOUSTON, Sept. 29, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that it has appointed Lippe Taylor Group as its consumer health public relations and customer engagement agency.

Key Points: 
  • HOUSTON, Sept. 29, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that it has appointed Lippe Taylor Group as its consumer health public relations and customer engagement agency.
  • Soliton's selection of Lippe Taylor Group is another step in advancing the U.S. commercialization of the Rapid Acoustic Pulse device in the first half of 2021.
  • "We look forward to working closely with Lippe Taylor Group and welcome them to the Soliton family."
  • "We are excited by the future of the Rapid Acoustic Pulse technology in accelerating and optimizing patient outcomes," said Paul Dyer, Chief Executive Officer of Lippe Taylor Group.

Soliton Enters into Distribution Agreement with Aesthetic Solutions, Inc. for Initial Commercial Launch of its RAP Device

Retrieved on: 
Thursday, September 10, 2020
Calculus, Differential equations, Multivariable calculus, Quasiparticles, Solitons, Rollout

Their team will sell and service the RAP devices until Soliton's direct sales force is fully established for the expected national rollout.

Key Points: 
  • Their team will sell and service the RAP devices until Soliton's direct sales force is fully established for the expected national rollout.
  • Join our more than 200K subscribers here to follow the Company: https://soly-investors.com
    "We are excited to have set in place a plan for the strategic distribution of our RAP device for our initial commercial launch," commented Christopher Capelli, MD, founder, President and CEO of Soliton.
  • Our relationship with Aesthetic Solutions represents a key step forward in accomplishing a successful commercial launch and we welcome their team as our sales and distribution partner."
  • Our highly trained sales and service staff teams are eager and ready to partner with Soliton to ensure success in the launch of this exciting multi-use device.

Soliton to Present at the Cantor Virtual Global Healthcare Conference

Retrieved on: 
Tuesday, September 8, 2020
Optics, Physics, Physical sciences, Nonlinear optics, Photonics, Quasiparticles, Soliton, Pulse, Laser

Audio webcasts of Soliton' presentations will be available on the investor relations section of Soliton's website at https://ir.soliton.com/ .

Key Points: 
  • Audio webcasts of Soliton' presentations will be available on the investor relations section of Soliton's website at https://ir.soliton.com/ .
  • The Company's first FDA cleared commercial product will use rapid pulses of acoustic shockwaves as an accessory to lasers for the removal of unwanted tattoos.
  • The Company is based in Houston, Texas, and is actively engaged in bringing the Rapid Acoustic Pulse ("RAP") device to the market.
  • Forward-looking statements in this press release include, without limitation, our ability to make a corporate presentation at the Cantor Virtual Global Healthcare Conference.

Soliton Reports Second Quarter 2020 Results

Retrieved on: 
Tuesday, August 11, 2020
Calculus, Differential equations, Multivariable calculus, Quasiparticles, Solitons

HOUSTON, Aug. 11, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the second quarter ended June 30, 2020.

Key Points: 
  • HOUSTON, Aug. 11, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the second quarter ended June 30, 2020.
  • Dr. Chris Capelli, Soliton's President, CEO and co-founder, commented, "During the second quarter of 2020, Soliton pivoted to a COVID-19 adjusted commercialization strategy.
  • Second Quarter 2020 Financial Results:
    Operating expenses for the second quarter ended June 30, 2020 were $3.1 million, as compared to $3.0 million in the second quarter 2019.
  • Net loss for the second quarter ended June 30, 2020 was $3.1 million, or $0.19 basic and diluted net loss per share, compared with net loss of $3.0 million, or $0.20 basic and diluted net loss per share, for the second quarter 2019.

Soliton Systems Announces Launch of Soliton NK, an Ultra-Fast Data Analytics Platform

Retrieved on: 
Monday, November 11, 2019
Solitons, Integrable systems, Partial differential equations, Fields of mathematics, Quasiparticles, Physical sciences, Topological defect, Mathematical analysis

Soliton NK supports a more efficient and cost effective way for SOCs to ingest data and establish corresponding cybersecurity measures.

Key Points: 
  • Soliton NK supports a more efficient and cost effective way for SOCs to ingest data and establish corresponding cybersecurity measures.
  • "The use cases for Soliton NK are far reaching," said Toru Tsuchiya, Executive Officer, Soliton Systems.
  • Ultra-fast data analytics and log analysis make the Soliton NK platform a top solution for corporations and public institutions that struggle with an excess of data.
  • Additionally, Soliton Systems is partnering with TomahawX to rapidly grow sales of their NK platform in the United States.

Soliton Announces Tattoo Technology Article Published in Medical Journal and Selected as Editor's Choice

Retrieved on: 
Thursday, October 3, 2019
Optics, Photonics, Nonlinear optics, Quasiparticles, Soliton, Laser

The article was selected as and will subsequently be featured by LSM as the Editors Choice paper.

Key Points: 
  • The article was selected as and will subsequently be featured by LSM as the Editors Choice paper.
  • The article can be viewed online via the following link:
    "We are truly pleased to have our article published in the 'Lasers in Surgery and Medicine' journal," commented Dr. Chris Capelli, President and CEO of Soliton, "given the high value Soliton places on developing its products with a foundation of real science.
  • Publication in this journal is true validation of our technology and trial results and selection by the editors for the 'Editor's Choice' paper is even more gratifying."
  • Join our more than 200K fans here to follow the Company: https://soly-investors.com
    Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from MD Anderson.